These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 25551621

  • 1. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y, Song KL, Chang H, Chen L.
    Diagn Pathol; 2014 Dec 31; 9():220. PubMed ID: 25551621
    [Abstract] [Full Text] [Related]

  • 2. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M, Shen D, Wang W, Xian J.
    Int J Clin Exp Pathol; 2015 Dec 31; 8(5):5542-8. PubMed ID: 26191262
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL, Chen LM, Wang WM, Zhang LM.
    Diagn Pathol; 2015 Apr 29; 10():45. PubMed ID: 25924779
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L, Cai X.
    Diagn Pathol; 2014 Dec 31; 9():1000. PubMed ID: 25552204
    [Abstract] [Full Text] [Related]

  • 5. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M, Li BY, Xia H, Jiang LL.
    Eur Rev Med Pharmacol Sci; 2017 May 31; 21(10):2346-2350. PubMed ID: 28617557
    [Abstract] [Full Text] [Related]

  • 6. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y, Mu N.
    Ann Clin Biochem; 2017 Jan 31; 54(1):127-133. PubMed ID: 27166306
    [Abstract] [Full Text] [Related]

  • 7. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
    Fang H, Shuang D, Yi Z, Sheng H, Liu Y.
    Biomed Pharmacother; 2016 Oct 31; 83():64-69. PubMed ID: 27470551
    [Abstract] [Full Text] [Related]

  • 8. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW, Liu N, Chen S, Wang Y, Zhang ZX, Sun YY, Qiu GB, Fu WN.
    Diagn Pathol; 2015 Apr 03; 10():22. PubMed ID: 25879432
    [Abstract] [Full Text] [Related]

  • 9. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W, Zhao ZY, Shi L, Yuan WD.
    Diagn Pathol; 2015 Jul 21; 10():116. PubMed ID: 26194657
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.
    Zhou J, Liu X, Wang CH, Wang D, Du JJ.
    Eur Rev Med Pharmacol Sci; 2018 May 21; 22(10):2997-3001. PubMed ID: 29863243
    [Abstract] [Full Text] [Related]

  • 11. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S, Kim J, Eom K, Oh S, Kim S, Kim G, Ahn S, Park KH, Chung D, Lee H.
    BMC Cancer; 2019 May 06; 19(1):419. PubMed ID: 31060525
    [Abstract] [Full Text] [Related]

  • 12. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
    Azizmohammadi S, Safari A, Azizmohammadi S, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R, Seifoleslami M.
    QJM; 2017 Jan 06; 110(1):11-15. PubMed ID: 27345415
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX.
    World J Gastroenterol; 2014 Aug 28; 20(32):11340-6. PubMed ID: 25170220
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L, Qu W, Zhong Z.
    Int J Clin Exp Pathol; 2015 Aug 28; 8(5):5609-13. PubMed ID: 26191272
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S, Yi XM, Zhou WQ, Cheng W, Ge JP, Zhang ZY.
    Int J Clin Exp Pathol; 2015 Aug 28; 8(11):14335-44. PubMed ID: 26823749
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L, Wang H.
    Diagn Pathol; 2013 Apr 30; 8():69. PubMed ID: 23631806
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of miR-664 in cervical cancer is associated with lower overall survival.
    Zhang YX, Qin LL, Yang SY.
    Eur Rev Med Pharmacol Sci; 2016 May 30; 20(9):1740-4. PubMed ID: 27212165
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
    Han Y, Xu GX, Lu H, Yu DH, Ren Y, Wang L, Huang XH, Hou WJ, Wei ZH, Chen YP, Cao YG, Zhang R.
    Int J Clin Exp Pathol; 2015 May 30; 8(6):7131-9. PubMed ID: 26261606
    [Abstract] [Full Text] [Related]

  • 19. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH, Zhang HH, Xu HF, Duan YJ, Li Q, Huang B.
    Genet Mol Res; 2015 Dec 07; 14(4):15948-54. PubMed ID: 26662386
    [Abstract] [Full Text] [Related]

  • 20. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y.
    Int J Clin Exp Pathol; 2015 Dec 07; 8(7):8394-401. PubMed ID: 26339409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.